Understanding mechanisms of gene expression control is perhaps the biggest challenge of the post genomic era. Protein abundance is regulated at all levels from transcription to protein degradation 1 . Current research mainly focuses on transcriptional control by activators and repressors that bind to specific DNA sequences. These interactions can now be studied on a genome-wide scale.
Chromatin immunoprecipitation followed by sequencing (ChIP-seq) generates genomic maps of interactions between proteins and their posttranslational modifications with DNA.
It is known for some time that the ubiquitin proteasome system (UPS) also plays a role in transcription 2 . In fact, one of the subunits of the proteasome was originally identified on the basis of mutations that suppressed defects in the yeast transcription activator Gal4 The model emerging from these data is straight forward: To activate transcription, a ubiquitin ligase (like Siah2 in this study) targets a transcriptional repressor (here NCoR1) for degradation, thus derepressing the gene (Fig. 1 A) . In this model, continuous degradation of the repressor is necessary for efficient transcription.
Alternatively, it is also conceivable that the UPS could target enhancers and thus represses specific genes (Fig. 1 B) . Finally, it is known that the UPS can remove "spent" transcription activators to allow binding of fresh molecules 4 . Thus, degradation of transcriptional enhancers can also increase transcription (Fig. 1 C) .
What are the functional implications? On one hand, targeted degradation of DNAassociated proteins adds another layer of regulation which may be required to achieve complex gene expression patterns. Accordingly, E3 ligases can be regarded as a novel class of trans-acting factors involved in transcription regulation. On the other hand, high turnover of DNA-binding proteins is also required for rapid changes in transcription. In fact, transcriptional regulators and chromatin-modifying enzymes tend to be unstable at both the protein and the mRNA level 8 . To some extent, chromatin-associated protein degradation may thus simply reflect the fact that many DNA-binding proteins are generally unstable.
As is the case for many pioneering papers, the work by Catic et al. opens up many questions. For example, except for NCoR1, it is not known which proteins are targeted. Proteomics could help quantifying changes in ubiquitination of individual proteins on a global scale 6, 9 . Moreover, the assay developed by the authors is indirect and does not prove that proteins are indeed degraded. The use of proteasome inhibitors is a particular concern because it is expected to induce unwanted side-effects. This could be addressed by using metabolic pulse labeling methods which can quantify protein turnover with less interference 10 . Future studies will provide new insights into the role of the UPS in transcriptional regulation. 
